sutimlimab

sutimlimab FDA Issues Complete Response Letter for Sutimlimab, an Investigational Treatment for Hemolysis in Adults with Cold Agglutinin Disease PARIS – November 13, 2020 – The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sutimlimab, an investigational monoclonal antibody for the treatment of hemolysis in adults with cold agglutinin disease. The […]

Continue reading »

HTX-011

Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain SAN DIEGO, Nov. 13, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the New Drug Application (NDA) was resubmitted to […]

Continue reading »

ALKS 3831

FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, Oct. 9, 2020 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced positive voting outcomes from the joint meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, appointed by the U.S. Food and Drug Administration (FDA). The committees met to discuss ALKS 3831 (olanzapine/samidorphan), an investigational, novel, […]

Continue reading »

Cerebral palsy also has genetic underpinnings

The causes of cerebral palsy have long been debated and often are attributed to in utero infections, premature birth, or brain injury to the baby near or during delivery, usually from a lack of oxygen. But many young children diagnosed with cerebral palsy have not experienced such events. Now, scientists have identified mutations in single genes that can be responsible […]

Continue reading »

pegcetacoplan

pegcetacoplan Apellis Announces Submission of Pegcetacoplan Marketing Applications to FDA and EMA for Patients with PNH WALTHAM, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and a Marketing Authorization Application (MAA) to […]

Continue reading »

Gender Identity

As our world continues to grow and we begin to recognize the diversity of people in our communities, part of this has been understanding that gender is not just the male and female that we may have been taught when we were younger. What is gender identity? Gender identity is a person’s internal feelings of being a woman, man, both, […]

Continue reading »

I have had trichotillomania for around 4-5 years and my mom wants to sign me up for a support group, but I kinda freak out when I talk in front of large groups even if it’s online and you can remain anonymous and not show your face. What should I do?

It is completely normal to be nervous about trying something new, especially when it involves sharing personal information with others. Most support groups are small, so it is unlikely that you will have to speak in front of a large number of people. You also can choose what and when you share – if you want to go to the […]

Continue reading »
1 2 3 14